A receptor fusion protein for the inhibition of murine oncostatin M
2011
Inhibiting Murine Oncostatin M with a Receptor Fusion Protein
publication
Evidence: high
Author Information
Author(s): Liv Brolund, Andrea Küster, Sabrina Korr, Michael Vogt, Gerhard Müller-Newen
Primary Institution: RWTH Aachen University
Hypothesis
Can receptor fusion proteins effectively inhibit murine oncostatin M?
Conclusion
The mOSM-RFP is a highly potent and specific inhibitor of murine oncostatin M.
Supporting Evidence
- The mOSM-RFP effectively blocks the activity of murine oncostatin M.
- Inhibitory activity was confirmed through experiments with murine embryonic fibroblasts.
- The receptor fusion proteins were shown to be specific inhibitors of mOSM.
Takeaway
Scientists created a special protein that can stop a harmful substance in mice that causes inflammation. This could help in treating diseases.
Methodology
The study involved constructing receptor fusion proteins and testing their inhibitory effects on murine embryonic fibroblasts.
Limitations
The study primarily focuses on murine models, which may not fully translate to human conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website